Skip to main content

Table 2 Descriptive data for all clinical parameters for the two groups and the three measurement points baseline, post treatment, follow-up (3 months). Means (standard deviations), difference scores at post-treatment and follow-up [95% confidence intervals] difference scores between groups are based on changes from baseline to post or from baseline to follow-up, respectively

From: Assessment of a taping method combined with manual therapy as a treatment of non-specific chronic low back pain – a randomized controlled trial

  Medi-Taping
Means (SDs) (n = 56)
Standard Care
Means (SDs) (n = 54)
Difference at Post-Treatment Difference at Follow-up
Baseline Post Follow-up Baseline Post Follow-up Means [95% CIs]b Means [95% CIs]b
VAS – Visual Analogue Scalea 5.17 (1.88) 3.31 (2.32) 3.30 (2.17) 5.66 (1.62) 4.19 (2.07) 4.60 (2.24) 0.38 [−0.45; 1.21] 0.81 [−0.11; 1.73]
CPGS – Korff Pain Grading Scalea 1.71 (0.76) 1.61 (0.78) 1.36 (0.59) 1.87 (0.70) 1.57 (0.79) 1.56 (0.79) -0.19 [−0.46; 0.08] 0.04 [−0.23; 0.32]
ODQ - Oswestry Disability quest.a 42.23 (13.24) 36.70 (14.42) 35.12 (12.47) 41.20 (12.61) 38.02 (14.26) 38.35 (13.47) 2.35 [−0.77; 5.48] 4.26 [0.43; 8.08]
PLC – Quality of Life Profile 15.65 (3.09) 17.16 (3.16) 16.97 (3.21) 15.32 (3.39) 15.71 (3.32) 15.65 (3.50) 1.12 [0.24;2.0] 0.99 [−0.15; 2.14]
LLD - Leg Length Difference (mm) 7.77 (5.27) 3.14 (3.89) 3.42 (3.15) 8.51 (5.66) 3.39 (3.17) 3.37 (3.36) −0.5 [−2.62;1.63] −0.8 [−2.9; 1.3]
FTF - Finger to Floor Distance (cm) 6.67 (10.61) 5.79 (10.15) 6.08 (9.60) 8.86 (9.12) 8.62 (8.88) 8.86 (8.74) 0.64 [−1.09; 2.37] 0.58 [−1.06; 2.22]
SS - Schober sign 14.54 (1.42) 13.99 (1.10) 14.31 (1.27) 14.49 (1.07) 14.15 (0.93) 14.39 (0.89) 0.21 [−0.18; 0.61] 0.13 [− 0.35; 0.61]
  1. aprimary outcomes at t2
  2. bnegative values for LLD and CPGS signal a higher benefit for the control group